Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

60.69

+0.02 (0.03%)

as of Jul 23, 2026, 8:00:00 pm Market Open.

1632 watching

Investor Insights

Jul 23, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has received mixed reviews from various experts, highlighting both its strengths and concerns. Many praise the company for its solid performance in Asia and wealth management, coupled with a healthy dividend yield, making it an attractive income stock. However, some analysts express caution due to overvaluation, suggesting that MFC may be overbought, trading at over 2x book value with slow earnings growth of around 8-9%. While the stock is seen as a reasonable long-term holding, there are calls for potential buying opportunities during market pullbacks. The general sentiment reflects a wait-and-see approach given the mixed indicators and the overall health of the financial sector.

Consensus

Cautious

Valuation

Fair Value

Similar

SLF

BUY

This would be his favourite in Canadian financials.

TOP PICK

(A Top Pick Nov 6/06. Up 6.4%.) Very good growth rate. Very nice ROE. Likes their international expansion. Expect there will be more acquisitions in the future. From the technical aspect, she feels it has been doing some basing.

BUY

The chart is a work of art. It just goes up. To calculate a stop loss, draw a straight line just below the bottom of the trend. As long as it stays above that line, don't worry about it.

BUY

Great company. Expecting 12% earnings growth. Good core holding for anyone's portfolio.

BUY

Sees more growth in the life companies than in the banks. Likes their Asian operations.

BUY

Had a big run late last year. Well managed. Good exposure in Asia.

BUY

Likes the long-term nature of the insurance companies with their wealth management.

BUY

Superbly run and gives good exposure to the US and the Far East.

BUY

Great company. Very well managed. Good track record. Very well exposed in Asia.

TOP PICK

(A Top Pick July 4/06. Up 11%.) Has actually been laggard in the group. John Hancock acquisition has been very successful. Still happy with it. ROE of over 16% and a PE of about 15.

BUY

A world-class Canadian company. One of the top 10 life-insurance companies in Japan. Making money in China.

BUY ON WEAKNESS

Likes it under $39. Well-run. Lots of growth in Asia. Decent US exposure.

BUY

His favourite insurance company in Canada. Best management. Great growth opportunities in the Far East. Have built up a lot of cash and have the ability to make a major acquisition.

BUY

Market was disappointed in their sales. He likes their prospects in Asia. Good long-term hold.

BUY

Would buy at this price.

Showing 1,816 to 1,830 of 2,283 entries

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Greg Newman

Scotia Wealth Management

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Jim Cramer - Mad Money

CNBC

John Stephenson

Stephenson & Company Capital Management

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)